Tuberin-dependent membrane localization of polycystin-1: A functional link between polycystic kidney disease and the TSC2 tumor suppressor gene

Molecular Cell

Volumn 7, Issue 4, 2001, Pages 823-832

  Kleymenova, Elena ^a   Ibraghimov Beskrovnaya, Oxana ^b   Kugoh, Hiroyuki ^a   Everitt, Jeff ^c   Xu, Hui ^a   Kiguchi, Kaoru ^a   Landes, Greg ^d   Harris, Peter ^e   Walker, Cheryl ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Genzyme Genetics   (United States)

^c CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^d Abgenix Inc   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; POLYCYSTIN; POLYCYSTIN 1; TUBERIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE DELETION; GENETIC ANALYSIS; GOLGI COMPLEX; KIDNEY CELL; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; RAT; SYNDROME; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0035019467     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00226-X     Document Type: Article

References (50)

1. Allan, B.B., and Balch, W.E. (1999). Protein sorting by directed maturation of Golgi compartments. Science 285, 63-66.
2. Bernstein, J. (1993). Renal cystic disease in the tuberous sclerosis complex. Pediatr. Nephrol. 7, 490-495.
3. Brook-Carter, P.T., Peral, B., Ward, C.J., Thompson, P., Hughes, J., Maheshwar, M.M., Nellist, M., Gamble, V., Harris, P.C., and Sampson, J.R. (1994). Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - a contiguous gene syndrome. Nat. Genet. 8, 328-332.
4. Eker, R., and Mossige, J. (1961). A dominant gene for renal adenomas in the rat. Nature 189, 858-859.
5. The European PKD Consortium. (1994). The polycystic kidney disease gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77, 881-894.
6. Everitt, J.I., Walker, C.L., Goldsworthy, T.W., and Wolf, D.C. (1997). Altered expression of transforming growth factor-alpha: an early event in renal cell carcinoma development. Mol. Carcinog. 19, 213-219.
7. Futter, C.E., Connolly, C.N., Cutler, D.F., and Hopkins, C.R. (1995). Newly synthesized transferrin receptors can be detected in the endosome before they appear on the cell surface. J. Biol. Chem. 270, 10999-11003.
8. Geberth, S., Ritz, E., Zeier, M., and Stier, E. (1995). Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD). Nephrol. Dial. Transplant 10, 1603-1606.
9. Gomez, M.R., Sampson, J.R., and Whittemore, V.H. (1999). Tuberous Sclerosis Complex. In Developmental Perspectives in Psychiatry, J.C. Harris, ed. (Oxford: Oxford University Press).
10. Grantham, J.J. (1990). Polycystic kidney disease: neoplasia in disguise. Am. J. Kidney Dis. 15, 110-116.
11. Griffin, M.D., Torres, V.E., Grande, J.P., and Kumar, R. (1996). Immunolocalization of polycystin in human tissues and cultured cells. Proc. Assoc. Am. Physicians 108, 185-197.
12. Hanaoka, K., Qian, F., Boletta, A., Bhunia, A., Piontek, K., Tsiokas, L., Sukhatme, V., Guggino, W.B., and Germino, G.G. (2000). Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408, 990-994.
13. Harris, P.C. (1997). The TSC2/PKD1 contiguous gene syndrome. Contrib. Nephrol. 122, 76-82.
14. Henry, K.W., Yuan, X., Koszewski, N.J., Onda, H., Kwiatkowski, D.J., and Noonan, D.J. (1998). Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J. Biol. Chem. 273, 20535-20539.
15. Hino, O., Klein-Szanto, A.J.P., Freed, J.J., Testa, J.R., Brown, D.Q., Vilensky, M., Yeung, R.S., Tartof, K.D., and Knudson, A.G. (1993). Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc. Natl. Acad. Sci. USA 90, 327-331.
16. Huan, Y., and van Adelsberg, J. (1999). Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J. Clin. Invest. 104, 1459-1468.
17. Hughes, J., Ward, C.J., Peral, B., Aspinwall, R., Clark, K., San Millan, J.L., Gamble, V., and Harris, P.C. (1995). The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10, 151-160.
18. Ibraghimov-Beskrovnaya, O., Dackowski, W.R., Foggensteiner, L., Coleman, N., Thiru, S., Petry, L.R., Burn, T.C., Connors, T.D., Van Raay, T., Bradley, J., et al. (1997). Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc. Natl. Acad. Sci. USA 94, 6397-6402.
19. Ibraghimov-Beskrovnaya, X., Bukanov, N.O., Donohue, L.C., Dackowski, W.R., Klinger, K.W., and Landes, G.M. (2000). Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Human Mol. Genet. 11, 1641-1649.
20. The International PKD Consortium. (1995). Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81, 289-298.
21. Keller, P., and Simons, K. (1997). Post-Golgi biosynthetic trafficking. J. Cell Sci. 110, 3001-3009.
22. Kim, E., Arnould, T., Sellin, L.K., Benzing, T., Fan, M.J., Gruning, W., Sokol, S.Y., Drummond, I., and Walz, G. (1999). The polycystic kidney disease 1 gene product modulates Wnt signaling. J. Biol. Chem. 274, 4947-4953.
23. Kim, K., Drummond, I., Ibraghimov-Beskrovnaya, O., Klinger, K., and Arnaout, M.A. (2000). Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl. Acad. Sci. USA 97, 1731-1736.
24. Kleymenova, E., Muga, S., Fischer, S., and Walker, C.L. (2000). Application of high-pressure liquid chromatography-based analysis of DNA fragments to molecular carcinogenesis. Mol. Carcinog. 29, 51-58.
25. Kleymenova, E.V., Bianchi, A.A., Kley, N., Pylev, L.N., and Walker, C.L. (1997). Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma. Mol. Carcinog. 18, 54-60.
26. Kobayashi, T., Hirayama, Y., Kobayashi, E., Kubo, Y., and Hino, O. (1995). A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat. Genet. 9, 70-74.
27. Lau, S.S., Monks, T.J., Everitt, J.I., Kleymenova, E., and Walker, C.L. (2001). Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone. Chem. Res. Toxicol. 14, 25-33.
28. Leitinger, B., Hille-Rehfeld, A., and Spiess, M. (1995). Biosynthetic transport of the asialoglycoprotein receptor H1 to the cell surface occurs via endosomes. Proc. Natl. Acad. Sci. USA 92, 10109-10113.
29. Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S.L., Veldhuisen, B., Saris, J.J., Reynolds, D.M., Cai, Y., Gabow, P.A., Pierides, A., et al. (1996). PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272, 1339-1342.
30. Palsson, R., Sharma, C.P., Kim, K., McLaughlin, M., Brown, D., and Arnaout, M.A. (1996). Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol. Med. 2, 702-711.
31. Peral, B., Ong, A.C., San Millan, J.L., Gamble, V., Rees, L., and Harris, P.C. (1996). A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1). Hum. Mol. Genet. 5, 539-542.
32. Peters, D.J., van de Wal, A., Spruit, L., Saris, J.J., Breuning, M.H., Bruijn, J.A., and de Heer, E. (1999). Cellular localization and tissue distribution of polycystin-1. J. Pathol. 188, 439-446.
33. Rennebeck, G., Kleymenova, E.V., Anderson, R., Yeung, R.S., Artzt, K., and Walker, C.L. (1998). Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc. Natl. Acad. Sci. USA 95, 15629-15634.
34. Sampson, J.R., Maheshwar, M.M., Aspinwall, R., Thompson, P., Cheadle, J.P., Ravine, D., Roy, S., Haan, E., Bernstein, J., and Harris, P.C. (1997). Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am. J. Hum. Genet. 61, 843-851.
35. Soucek, T., Pusch, O., Wienecke, R., DeClue, J.E., and Hengstschlager, M. (1997). Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J. Biol. Chem. 272, 29301-29308.
36. Soucek, T., Yeung, R.S., and Hengstschlager, M. (1998). Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. USA 95, 15653-15658.
37. Tooze, J., and Hollinshead, M. (1992). In AtT20 and HeLa cells brefeldin A induces the fusion of tubular endosomes and changes their distribution and some of their endocytic properties. J. Cell Biol. 118, 813-830.
38. Walker, C.W., Goldsworthy, T.L., Wolf, D.C., and Everitt, J. (1992). Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. Science 255, 1693-1695.
39. Walker, C., and Ginsler, J. (1992). Development of a quantitative in vitro transformation assay for kidney epithelial cells. Carcinogenesis 13, 25-32.
40. Ward, C.J., Turley, H., Ong, A.C., Comley, M., Biddolph, S., Chetty, R., Ratcliffe, P.J., Gattner, K., and Harris, P.C. (1996). Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc. Natl. Acad. Sci. USA 93, 1524-1528.
41. Wienecke, R., Konig, A., and DeClue, J.E. (1995). Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 270, 16409-16414.
42. Wienecke, R., Maize, J.C., Jr., Shoarinejad, F., Vass, W.C., Reed, J., Bonifacino, J.S., Resau, J.H., de Gunzburg, J., Yeung, R.S., and DeClue, J.E. (1996). Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 13, 913-923.
43. Wilson, P.D. (1996). Pathogenesis of Polycystic Kidney Disease: Altered Cellular Function. In Polycystic Kidney Diseases, M.L. Watson and V.E. Torres, eds. (Oxford: Oxford Medical Publications), pp. 125-163.
44. Wilson, P.D., Geng, L., Li, X., and Burrow, C.R. (1999). The PKD1 gene product, "Polycystin-1", is a tyrosine-phosphorylated protein that colocalizes with α2β1 in-integrin in focal clusters in adherent renal epithelial. Lab. Invest. 79, 1311-1323.
45. Wood, S.A., Park, J.E., and Brown, W.J. (1991). Brefeldin A causes a microtubule-mediated fusion of the trans-Golgi network and early endosomes. Cell 67, 591-600.
46. Wood, S.A., and Brown, W.J. (1992). The morphology but not the function of endosomes and lysosomes is altered by brefeldin A. J. Cell Biol. 119, 273-285.
47. Xiao, G.H., Shoarinejad, F., Jin, F., Golemis, E.A., and Yeung, R.S. (1997). The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J. Biol. Chem. 272, 6097-6100.
48. Yeung, R.S., Xiao, G.H., Everitt, J.I., Jin, F., and Walker, C.L. (1995). Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol. Carcinog. 14, 28-36.
49. Yeung, R.S., Xiao, G.H., Jin, F., Lee, W.C., Testa, J.R., and Knudson, A.G. (1994). Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc. Natl. Acad. Sci. USA 91, 11413-11416.
50. Young, J., and Povey, S. (1998). The genetic basis of tuberous sclerosis. Mol. Med. Today 4, 313-319.